Federal Register / Vol. 65, No. 188 / Wednesday, September 27, 2000 / Notices 58095

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Initial Review Group, Subcommittee

G—Education.

Date: October 11–13, 2000.

Time: 12 p.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Harvey P. Stein, Scientific

Review Administrator, Grants Review

Branch, Division of Extramural Activities,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

8036, Bethesda, MD 20892, 301/496–7841.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24730 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Board of Scientific Counselors, National

Institute of Mental Health.

The meeting will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Institute of Mental Health,

including consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Institute of Mental

Health.

Date: October 4, 2000.

Time: 8:30 a.m. to 2 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Institutes of Health, 9000

Rockville Pike, Building 10, Room 4N230,

Bethesda, MD 20892.

Contact Person: Susan Koester, Executive

Secretary, Associate Director for Science,

Intramural Research Program, National

Institute of Mental Health, NIH, Building 10,

Room 4N222, MSC 1381, Bethesda, MD

20892–1381, 301–496–3501.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the intramural research review cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: September 15, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–24721 Filed 9–26–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Treatment

Research Subcommittee.

Date: October 17, 2000.

Time: 9 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Washington, 515 15th Street,

NW., Washington, DC 20004.

Contact Person: Kesinee Nimit, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1432.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Health

Services Research Subcommittee.

Date: October 17–18, 2000.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Washington, 515 15th Street,

NW., Washington, DC 20004.

Contact Person: Marina L. Volkov, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1433.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

Treatment Research.

Date: October 17, 2000.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Washington, 515 15th Street,

NW., Washington, DC 20004.

Contact Person: William C. Grace, Deputy

Director, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2755.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Health

Services Research.

Date: October 18, 2000.

Time: 11 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Washington, 515 15th Street,

NW., Washington, DC 20004.

Contact Person: Kesinee Nimit, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1432.

Name of Committee: National Institute on

Drug Abuse Initial Review Group,

Medication Development Research

Subcommittee.

Date: November 1–2, 2000.

Time: 9 a.m. to 4 p.m.